statement
헬스케어 revenue was 238억원 (-0.1%), falling short of expectations on top-line growth but improving profitability versus the prior quarter.
A statement by 3Q26 Review. Statements are as reported by the cited publishers — not verified by DecisionGateway.
헬스케어는 매출 238억원(-0.1%)으로 외형 성장은 기대에 미치지 못했으나 전분기 대비 수익성 개선
Discussion
Related claims
4Q26 revenue is forecast at 1,130억원 (+14.3%) and operating profit at 137억원 (+32.2%, OPM 12.1%), with margin expected to fall versus 3Q on year-end costs and pre-investment in 헬스케어 new products and overseas expansion.4Q26 전망 · prediction헥토이노베이션 achieved a record quarterly operating profit in 3Q26 on the back of high growth at its fintech and healthcare subsidiaries.post author · statementCosmecca Korea's revenue grew excessively; despite profitability decline, it focused on meeting customer delivery deadlines, and domestic revenue exceeded 200 billion won for the first time while OPM fell to the 11% range, showing willingness to expand business scale despite short-term profitability damage.하나증권 유통/화장품 박종대 · statementResponse to 헥토헬스케어's premium new products is favorable and the product portfolio is being expanded.post author · statementRevenue came in 6.3% below the firm's estimate, while operating profit exceeded it by 2.6%.3Q26 Review · statement헥토이노베이션 recorded 3Q26 consolidated revenue of 108.83 billion KRW and operating profit of 15.26 billion KRW, its largest quarterly operating profit.post author · statement